Literature DB >> 25776750

Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification.

Chanthiwa Wikraiphat1, Natnaree Saiprom2, Sarunporn Tandhavanant3, Christian Heiss4, Parastoo Azadi4, Gumphol Wongsuvan1, Apichai Tuanyok5, Matthew T G Holden6, Mary N Burtnick7, Paul J Brett7, Sharon J Peacock8, Narisara Chantratita9.   

Abstract

Burkholderia pseudomallei is a CDC tier 1 select agent that causes melioidosis, a severe disease in humans and animals. Persistent infections are common, and there is currently no vaccine available. Lipopolysaccharide (LPS) is a potential vaccine candidate. B. pseudomallei expresses three serologically distinct LPS types. The predominant O-polysaccharide (OPS) is an unbranched heteropolymer with repeating d-glucose and 6-deoxy-l-talose residues in which the 6-deoxy-l-talose residues are variably replaced with O-acetyl and O-methyl modifications. We observed that primary clinical B. pseudomallei isolates with mucoid and nonmucoid colony morphologies from the same sample expressed different antigenic types distinguishable using an LPS-specific monoclonal antibody (MAb). MAb-reactive (nonmucoid) and nonreactive (mucoid) strains from the same patient exhibited identical LPS banding patterns by silver staining and indistinguishable genotypes. We hypothesized that LPS antigenic variation reflected modification of the OPS moieties. Mutagenesis of three genes involved in LPS synthesis was performed in B. pseudomallei K96243. Loss of MAb reactivity was observed in both wbiA (encoding a 2-O-acetyltransferase) and wbiD (putative methyl transferase) mutants. The structural characteristics of the OPS moieties from isogenic nonmucoid strain 4095a and mucoid strain 4095c were further investigated. Utilizing nuclear magnetic resonance (NMR) spectroscopy, we found that B. pseudomallei 4095a and 4095c OPS antigens exhibited substitution patterns that differed from the prototypic OPS structure. Specifically, 4095a lacked 4-O-acetylation, while 4095c lacked both 4-O-acetylation and 2-O-methylation. Our studies indicate that B. pseudomallei OPS undergoes antigenic variation and suggest that the 9D5 MAb recognizes a conformational epitope that is influenced by both O-acetyl and O-methyl substitution patterns.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25776750      PMCID: PMC4399047          DOI: 10.1128/IAI.02785-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei.

Authors:  Narisara Chantratita; Vanaporn Wuthiekanun; Khaemaporn Boonbumrung; Rachaneeporn Tiyawisutsri; Mongkol Vesaratchavest; Direk Limmathurotsakul; Wirongrong Chierakul; Surasakdi Wongratanacheewin; Sasithorn Pukritiyakamee; Nicholas J White; Nicholas P J Day; Sharon J Peacock
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

2.  Serodiagnosis of melioidosis by a competitive enzyme-linked immunosorbent assay using a lipopolysaccharide-specific monoclonal antibody.

Authors:  Charin Thepthai; Saijai Smithtikarn; Montana Suksuwan; Sirirurg Songsivilai; Tararaj Dharakul
Journal:  Asian Pac J Allergy Immunol       Date:  2005 Jun-Sep       Impact factor: 2.310

3.  Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.

Authors:  Paul J Brett; Mary N Burtnick; Christian Heiss; Parastoo Azadi; David DeShazer; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

4.  Increasing incidence of human melioidosis in Northeast Thailand.

Authors:  Direk Limmathurotsakul; Surasakdi Wongratanacheewin; Nittaya Teerawattanasook; Gumphol Wongsuvan; Seksan Chaisuksant; Ploenchan Chetchotisakd; Wipada Chaowagul; Nicholas P J Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

5.  Versatile dual-technology system for markerless allele replacement in Burkholderia pseudomallei.

Authors:  Carolina M López; Drew A Rholl; Lily A Trunck; Herbert P Schweizer
Journal:  Appl Environ Microbiol       Date:  2009-08-21       Impact factor: 4.792

6.  A LysR-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence.

Authors:  Steve P Bernier; David T Nguyen; Pamela A Sokol
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

7.  Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins.

Authors:  Narisara Anuntagool; Vanaporn Wuthiekanun; Nicholas J White; Bart J Currie; Rasana W Sermswan; Surasakdi Wongratanacheewin; Suwimol Taweechaisupapong; Sansanee C Chaiyaroj; Stitaya Sirisinha
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

8.  Effect of colony morphology variation of Burkholderia pseudomallei on intracellular survival and resistance to antimicrobial environments in human macrophages in vitro.

Authors:  Sarunporn Tandhavanant; Aunchalee Thanwisai; Direk Limmathurotsakul; Sunee Korbsrisate; Nicholas Pj Day; Sharon J Peacock; Narisara Chantratita
Journal:  BMC Microbiol       Date:  2010-11-30       Impact factor: 3.605

9.  Survival of Burkholderia pseudomallei in distilled water for 16 years.

Authors:  Apinya Pumpuang; Narisara Chantratita; Chanthiwa Wikraiphat; Natnaree Saiprom; Nicholas P J Day; Sharon J Peacock; Vanaporn Wuthiekanun
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-20       Impact factor: 2.184

10.  Differential intracellular fate of Burkholderia pseudomallei 844 and Burkholderia thailandensis UE5 in human monocyte-derived dendritic cells and macrophages.

Authors:  Jaruek Charoensap; Pongsak Utaisincharoen; Anneke Engering; Stitaya Sirisinha
Journal:  BMC Immunol       Date:  2009-04-27       Impact factor: 3.615

View more
  14 in total

1.  Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848.

Authors:  David DeShazer; Sean Lovett; Joshua Richardson; Galina Koroleva; Kathleen Kuehl; Kei Amemiya; Mei Sun; Patricia Worsham; Susan Welkos
Journal:  J Med Microbiol       Date:  2019-01-10       Impact factor: 2.472

2.  Clinical Utility of Combined Whole-cell Antigen and Recombinant Hemolysis Co-regulated Protein 1-Enzyme-linked Immunosorbent Assays Reveals Underdiagnosed Cases of Melioidosis in Vietnam.

Authors:  Quyen T L Tran; Ha V Nguyen; Huyen T Pham; Tuan V Mai; Quyen H M Nguyen; Dzung V Le; Linh N H Bui; Lan T H Hoang; Trung Q Hoang; Trung T Trinh
Journal:  Am J Trop Med Hyg       Date:  2022-07-25       Impact factor: 3.707

3.  Rapid Clinical Screening of Burkholderia pseudomallei Colonies by a Bacteriophage Tail Fiber-Based Latex Agglutination Assay.

Authors:  Veerachat Muangsombut; Patoo Withatanung; Narisara Chantratita; Sorujsiri Chareonsudjai; Jiali Lim; Edouard E Galyov; Orawan Ottiwet; Sineenart Sengyee; Sujintana Janesomboon; Martin J Loessner; Matthew Dunne; Sunee Korbsrisate
Journal:  Appl Environ Microbiol       Date:  2021-05-26       Impact factor: 4.792

4.  Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.

Authors:  Vichaya Suttisunhakul; Vanaporn Wuthiekanun; Paul J Brett; Srisin Khusmith; Nicholas P J Day; Mary N Burtnick; Direk Limmathurotsakul; Narisara Chantratita
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

5.  Susceptibility of Clinical Isolates of Burkholderia pseudomallei to a Lipid A Biosynthesis Inhibitor.

Authors:  Sineenart Sengyee; Natnaree Saiprom; Suporn Paksanont; Direk Limmathurotsakul; Vanaporn Wuthiekanun; Narisara Chantratita
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

6.  Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.

Authors:  Marielle Tamigney Kenfack; Marcelina Mazur; Teerapat Nualnoi; Teresa L Shaffer; Abba Ngassimou; Yves Blériot; Jérôme Marrot; Roberta Marchetti; Kitisak Sintiprungrat; Narisara Chantratita; Alba Silipo; Antonio Molinaro; David P AuCoin; Mary N Burtnick; Paul J Brett; Charles Gauthier
Journal:  Nat Commun       Date:  2017-07-24       Impact factor: 14.919

7.  Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.

Authors:  R C Bernhards; C K Cote; K Amemiya; D M Waag; C P Klimko; P L Worsham; S L Welkos
Journal:  Arch Microbiol       Date:  2016-10-13       Impact factor: 2.552

8.  Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.

Authors:  A A Shea; R C Bernhards; C K Cote; C J Chase; J W Koehler; C P Klimko; J T Ladner; D A Rozak; M J Wolcott; D P Fetterer; S J Kern; G I Koroleva; S P Lovett; G F Palacios; R G Toothman; J A Bozue; P L Worsham; S L Welkos
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

9.  Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosis.

Authors:  Apinya Pumpuang; Susanna J Dunachie; Phornpun Phokrai; Kemajittra Jenjaroen; Kitisak Sintiprungrat; Siriphan Boonsilp; Paul J Brett; Mary N Burtnick; Narisara Chantratita
Journal:  PLoS Negl Trop Dis       Date:  2017-03-30

10.  Genome-scale analysis of the genes that contribute to Burkholderia pseudomallei biofilm formation identifies a crucial exopolysaccharide biosynthesis gene cluster.

Authors:  Grace I Borlee; Brooke A Plumley; Kevin H Martin; Nawarat Somprasong; Mihnea R Mangalea; M Nurul Islam; Mary N Burtnick; Paul J Brett; Ivo Steinmetz; David P AuCoin; John T Belisle; Dean C Crick; Herbert P Schweizer; Bradley R Borlee
Journal:  PLoS Negl Trop Dis       Date:  2017-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.